GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Earnings per Share (Diluted)

LSB (LakeShore Biopharma Co) Earnings per Share (Diluted) : $-2.90 (TTM As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Earnings per Share (Diluted)?

LakeShore Biopharma Co's Earnings per Share (Diluted) for the three months ended in Sep. 2023 was $-1.55. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.90.

LakeShore Biopharma Co's EPS (Basic) for the three months ended in Sep. 2023 was $-1.55. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.90.

LakeShore Biopharma Co's EPS without NRI for the three months ended in Sep. 2023 was $-1.55. Its EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 was $-2.80.

During the past 3 years, the average EPS without NRIGrowth Rate was -5.30% per year.

During the past 4 years, LakeShore Biopharma Co's highest 3-Year average EPS without NRI Growth Rate was -5.30% per year. The lowest was -5.30% per year. And the median was -5.30% per year.


LakeShore Biopharma Co Earnings per Share (Diluted) Historical Data

The historical data trend for LakeShore Biopharma Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Earnings per Share (Diluted) Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Earnings per Share (Diluted)
-3.47 -4.05 -4.42 -5.62

LakeShore Biopharma Co Quarterly Data
Mar21 Sep21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only -0.45 -0.31 -1.04 -1.55 -0.30

Competitive Comparison of LakeShore Biopharma Co's Earnings per Share (Diluted)

For the Biotechnology subindustry, LakeShore Biopharma Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's PE Ratio falls into.



LakeShore Biopharma Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

LakeShore Biopharma Co's Earnings Per Share (Diluted) for the fiscal year that ended in Mar. 2024 is calculated as

Diluted Earnings Per Share (A: Mar. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-60.191-0)/10.692
=-5.63

LakeShore Biopharma Co's Earnings Per Share (Diluted) for the quarter that ended in Sep. 2023 is calculated as

Diluted Earnings Per Share (Q: Sep. 2023 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-14.385-0)/9.306
=-1.55

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.90

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


LakeShore Biopharma Co  (NAS:LSB) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


LakeShore Biopharma Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


LakeShore Biopharma Co Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.